Rotavirus vaccine is a vaccine used to protect against rotavirus infections, which are the leading cause of severe diarrhea among young children. The vaccines prevent 15?34% of severe diarrhea in the developing world and 37?96% of severe diarrhea in the developed world. The vaccines decrease the risk of death among young children due to diarrhea. Immunizing babies decreases rates of disease among older people and those who have not been immunized.
The World Health Organization (WHO) recommends that rotavirus vaccine be included in national routine vaccinations programs, especially in areas where the disease is common. This should be done along with promoting breastfeeding, handwashing, clean water and good sanitation. It is given by mouth and requires two or three doses. It should be given starting around six weeks of age.
The vaccines are safe. This includes their use in people with HIV/AIDS. An earlier vaccine that is no longer used was linked to intussusception, but the current versions are not clearly linked. Due to a potential risk they are not recommended in babies who have had intussusception. The vaccines are made from weakened rotavirus.
The vaccine first became available in the United States in 2006. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between US$6.96 and $20.66 per dose as of 2014.In the United States it is more than US$200. As of 2013 there are two types of vaccine available globally, Rotarix and RotaTeq. Others are used in some countries.
This report aims to provide a comprehensive presentation of the global market for Rotavirus Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rotavirus Vaccines. This report contains market size and forecasts of Rotavirus Vaccines in global, including the following market information:
Global Rotavirus Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Rotavirus Vaccines Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Rotavirus Vaccines companies in 2022 (%)
The global Rotavirus Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Rotarix Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Rotavirus Vaccines include Bharat Biotech, Merck & Co., Inc, GlaxoSmithKline plc, Lanzhou Institute of Biological and Bharat Biotech International Limited, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Rotavirus Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rotavirus Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Rotavirus Vaccines Market Segment Percentages, by Type, 2022 (%)
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Others
Global Rotavirus Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Rotavirus Vaccines Market Segment Percentages, by Application, 2022 (%)
Adult
Pediatric
Global Rotavirus Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Rotavirus Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rotavirus Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Rotavirus Vaccines revenues share in global market, 2022 (%)
Key companies Rotavirus Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Rotavirus Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bharat Biotech
Merck & Co., Inc
GlaxoSmithKline plc
Lanzhou Institute of Biological
Bharat Biotech International Limited
Outline of Major Chapters:
Chapter 1: Introduces the definition of Rotavirus Vaccines, market overview.
Chapter 2: Global Rotavirus Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Rotavirus Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Rotavirus Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Rotavirus Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Rotavirus Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Rotavirus Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Rotavirus Vaccines Overall Market Size
2.1 Global Rotavirus Vaccines Market Size: 2022 VS 2029
2.2 Global Rotavirus Vaccines Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Rotavirus Vaccines Sales: 2018-2029
3 Company Landscape
3.1 Top Rotavirus Vaccines Players in Global Market
3.2 Top Global Rotavirus Vaccines Companies Ranked by Revenue
3.3 Global Rotavirus Vaccines Revenue by Companies
3.4 Global Rotavirus Vaccines Sales by Companies
3.5 Global Rotavirus Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Rotavirus Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Rotavirus Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Rotavirus Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Rotavirus Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Rotavirus Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Rotavirus Vaccines Market Size Markets, 2022 & 2029
4.1.2 Rotarix
4.1.3 RotaTeq
4.1.4 Rotavac
4.1.5 Rotavin-M1
4.1.6 Lanzhou lamb
4.1.7 Others
4.2 By Type - Global Rotavirus Vaccines Revenue & Forecasts
4.2.1 By Type - Global Rotavirus Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Rotavirus Vaccines Revenue, 2024-2029
4.2.3 By Type - Global Rotavirus Vaccines Revenue Market Share, 2018-2029
4.3 By Type - Global Rotavirus Vaccines Sales & Forecasts
4.3.1 By Type - Global Rotavirus Vaccines Sales, 2018-2023
4.3.2 By Type - Global Rotavirus Vaccines Sales, 2024-2029
4.3.3 By Type - Global Rotavirus Vaccines Sales Market Share, 2018-2029
4.4 By Type - Global Rotavirus Vaccines Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Rotavirus Vaccines Market Size, 2022 & 2029
5.1.2 Adult
5.1.3 Pediatric
5.2 By Application - Global Rotavirus Vaccines Revenue & Forecasts
5.2.1 By Application - Global Rotavirus Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Rotavirus Vaccines Revenue, 2024-2029
5.2.3 By Application - Global Rotavirus Vaccines Revenue Market Share, 2018-2029
5.3 By Application - Global Rotavirus Vaccines Sales & Forecasts
5.3.1 By Application - Global Rotavirus Vaccines Sales, 2018-2023
5.3.2 By Application - Global Rotavirus Vaccines Sales, 2024-2029
5.3.3 By Application - Global Rotavirus Vaccines Sales Market Share, 2018-2029
5.4 By Application - Global Rotavirus Vaccines Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Rotavirus Vaccines Market Size, 2022 & 2029
6.2 By Region - Global Rotavirus Vaccines Revenue & Forecasts
6.2.1 By Region - Global Rotavirus Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Rotavirus Vaccines Revenue, 2024-2029
6.2.3 By Region - Global Rotavirus Vaccines Revenue Market Share, 2018-2029
6.3 By Region - Global Rotavirus Vaccines Sales & Forecasts
6.3.1 By Region - Global Rotavirus Vaccines Sales, 2018-2023
6.3.2 By Region - Global Rotavirus Vaccines Sales, 2024-2029
6.3.3 By Region - Global Rotavirus Vaccines Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Rotavirus Vaccines Revenue, 2018-2029
6.4.2 By Country - North America Rotavirus Vaccines Sales, 2018-2029
6.4.3 US Rotavirus Vaccines Market Size, 2018-2029
6.4.4 Canada Rotavirus Vaccines Market Size, 2018-2029
6.4.5 Mexico Rotavirus Vaccines Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Rotavirus Vaccines Revenue, 2018-2029
6.5.2 By Country - Europe Rotavirus Vaccines Sales, 2018-2029
6.5.3 Germany Rotavirus Vaccines Market Size, 2018-2029
6.5.4 France Rotavirus Vaccines Market Size, 2018-2029
6.5.5 U.K. Rotavirus Vaccines Market Size, 2018-2029
6.5.6 Italy Rotavirus Vaccines Market Size, 2018-2029
6.5.7 Russia Rotavirus Vaccines Market Size, 2018-2029
6.5.8 Nordic Countries Rotavirus Vaccines Market Size, 2018-2029
6.5.9 Benelux Rotavirus Vaccines Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Rotavirus Vaccines Revenue, 2018-2029
6.6.2 By Region - Asia Rotavirus Vaccines Sales, 2018-2029
6.6.3 China Rotavirus Vaccines Market Size, 2018-2029
6.6.4 Japan Rotavirus Vaccines Market Size, 2018-2029
6.6.5 South Korea Rotavirus Vaccines Market Size, 2018-2029
6.6.6 Southeast Asia Rotavirus Vaccines Market Size, 2018-2029
6.6.7 India Rotavirus Vaccines Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Rotavirus Vaccines Revenue, 2018-2029
6.7.2 By Country - South America Rotavirus Vaccines Sales, 2018-2029
6.7.3 Brazil Rotavirus Vaccines Market Size, 2018-2029
6.7.4 Argentina Rotavirus Vaccines Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Rotavirus Vaccines Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Rotavirus Vaccines Sales, 2018-2029
6.8.3 Turkey Rotavirus Vaccines Market Size, 2018-2029
6.8.4 Israel Rotavirus Vaccines Market Size, 2018-2029
6.8.5 Saudi Arabia Rotavirus Vaccines Market Size, 2018-2029
6.8.6 UAE Rotavirus Vaccines Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bharat Biotech
7.1.1 Bharat Biotech Company Summary
7.1.2 Bharat Biotech Business Overview
7.1.3 Bharat Biotech Rotavirus Vaccines Major Product Offerings
7.1.4 Bharat Biotech Rotavirus Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 Bharat Biotech Key News & Latest Developments
7.2 Merck & Co., Inc
7.2.1 Merck & Co., Inc Company Summary
7.2.2 Merck & Co., Inc Business Overview
7.2.3 Merck & Co., Inc Rotavirus Vaccines Major Product Offerings
7.2.4 Merck & Co., Inc Rotavirus Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 Merck & Co., Inc Key News & Latest Developments
7.3 GlaxoSmithKline plc
7.3.1 GlaxoSmithKline plc Company Summary
7.3.2 GlaxoSmithKline plc Business Overview
7.3.3 GlaxoSmithKline plc Rotavirus Vaccines Major Product Offerings
7.3.4 GlaxoSmithKline plc Rotavirus Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 GlaxoSmithKline plc Key News & Latest Developments
7.4 Lanzhou Institute of Biological
7.4.1 Lanzhou Institute of Biological Company Summary
7.4.2 Lanzhou Institute of Biological Business Overview
7.4.3 Lanzhou Institute of Biological Rotavirus Vaccines Major Product Offerings
7.4.4 Lanzhou Institute of Biological Rotavirus Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 Lanzhou Institute of Biological Key News & Latest Developments
7.5 Bharat Biotech International Limited
7.5.1 Bharat Biotech International Limited Company Summary
7.5.2 Bharat Biotech International Limited Business Overview
7.5.3 Bharat Biotech International Limited Rotavirus Vaccines Major Product Offerings
7.5.4 Bharat Biotech International Limited Rotavirus Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 Bharat Biotech International Limited Key News & Latest Developments
8 Global Rotavirus Vaccines Production Capacity, Analysis
8.1 Global Rotavirus Vaccines Production Capacity, 2018-2029
8.2 Rotavirus Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Rotavirus Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Rotavirus Vaccines Supply Chain Analysis
10.1 Rotavirus Vaccines Industry Value Chain
10.2 Rotavirus Vaccines Upstream Market
10.3 Rotavirus Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Rotavirus Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Rotavirus Vaccines in Global Market
Table 2. Top Rotavirus Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Rotavirus Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Rotavirus Vaccines Revenue Share by Companies, 2018-2023
Table 5. Global Rotavirus Vaccines Sales by Companies, (K Units), 2018-2023
Table 6. Global Rotavirus Vaccines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Rotavirus Vaccines Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Rotavirus Vaccines Product Type
Table 9. List of Global Tier 1 Rotavirus Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rotavirus Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Rotavirus Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Rotavirus Vaccines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Rotavirus Vaccines Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Rotavirus Vaccines Sales (K Units), 2018-2023
Table 15. By Type - Global Rotavirus Vaccines Sales (K Units), 2024-2029
Table 16. By Application ? Global Rotavirus Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Rotavirus Vaccines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Rotavirus Vaccines Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Rotavirus Vaccines Sales (K Units), 2018-2023
Table 20. By Application - Global Rotavirus Vaccines Sales (K Units), 2024-2029
Table 21. By Region ? Global Rotavirus Vaccines Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Rotavirus Vaccines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Rotavirus Vaccines Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Rotavirus Vaccines Sales (K Units), 2018-2023
Table 25. By Region - Global Rotavirus Vaccines Sales (K Units), 2024-2029
Table 26. By Country - North America Rotavirus Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Rotavirus Vaccines Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Rotavirus Vaccines Sales, (K Units), 2018-2023
Table 29. By Country - North America Rotavirus Vaccines Sales, (K Units), 2024-2029
Table 30. By Country - Europe Rotavirus Vaccines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Rotavirus Vaccines Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Rotavirus Vaccines Sales, (K Units), 2018-2023
Table 33. By Country - Europe Rotavirus Vaccines Sales, (K Units), 2024-2029
Table 34. By Region - Asia Rotavirus Vaccines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Rotavirus Vaccines Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Rotavirus Vaccines Sales, (K Units), 2018-2023
Table 37. By Region - Asia Rotavirus Vaccines Sales, (K Units), 2024-2029
Table 38. By Country - South America Rotavirus Vaccines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Rotavirus Vaccines Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Rotavirus Vaccines Sales, (K Units), 2018-2023
Table 41. By Country - South America Rotavirus Vaccines Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Rotavirus Vaccines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Rotavirus Vaccines Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Rotavirus Vaccines Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Rotavirus Vaccines Sales, (K Units), 2024-2029
Table 46. Bharat Biotech Company Summary
Table 47. Bharat Biotech Rotavirus Vaccines Product Offerings
Table 48. Bharat Biotech Rotavirus Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Bharat Biotech Key News & Latest Developments
Table 50. Merck & Co., Inc Company Summary
Table 51. Merck & Co., Inc Rotavirus Vaccines Product Offerings
Table 52. Merck & Co., Inc Rotavirus Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Merck & Co., Inc Key News & Latest Developments
Table 54. GlaxoSmithKline plc Company Summary
Table 55. GlaxoSmithKline plc Rotavirus Vaccines Product Offerings
Table 56. GlaxoSmithKline plc Rotavirus Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. GlaxoSmithKline plc Key News & Latest Developments
Table 58. Lanzhou Institute of Biological Company Summary
Table 59. Lanzhou Institute of Biological Rotavirus Vaccines Product Offerings
Table 60. Lanzhou Institute of Biological Rotavirus Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Lanzhou Institute of Biological Key News & Latest Developments
Table 62. Bharat Biotech International Limited Company Summary
Table 63. Bharat Biotech International Limited Rotavirus Vaccines Product Offerings
Table 64. Bharat Biotech International Limited Rotavirus Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Bharat Biotech International Limited Key News & Latest Developments
Table 66. Rotavirus Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 67. Global Rotavirus Vaccines Capacity Market Share of Key Manufacturers, 2021-2023
Table 68. Global Rotavirus Vaccines Production by Region, 2018-2023 (K Units)
Table 69. Global Rotavirus Vaccines Production by Region, 2024-2029 (K Units)
Table 70. Rotavirus Vaccines Market Opportunities & Trends in Global Market
Table 71. Rotavirus Vaccines Market Drivers in Global Market
Table 72. Rotavirus Vaccines Market Restraints in Global Market
Table 73. Rotavirus Vaccines Raw Materials
Table 74. Rotavirus Vaccines Raw Materials Suppliers in Global Market
Table 75. Typical Rotavirus Vaccines Downstream
Table 76. Rotavirus Vaccines Downstream Clients in Global Market
Table 77. Rotavirus Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Rotavirus Vaccines Segment by Type in 2022
Figure 2. Rotavirus Vaccines Segment by Application in 2022
Figure 3. Global Rotavirus Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Rotavirus Vaccines Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Rotavirus Vaccines Revenue, 2018-2029 (US$, Mn)
Figure 7. Rotavirus Vaccines Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Rotavirus Vaccines Revenue in 2022
Figure 9. By Type - Global Rotavirus Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Rotavirus Vaccines Revenue Market Share, 2018-2029
Figure 11. By Type - Global Rotavirus Vaccines Sales Market Share, 2018-2029
Figure 12. By Type - Global Rotavirus Vaccines Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Rotavirus Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Rotavirus Vaccines Revenue Market Share, 2018-2029
Figure 15. By Application - Global Rotavirus Vaccines Sales Market Share, 2018-2029
Figure 16. By Application - Global Rotavirus Vaccines Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Rotavirus Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Rotavirus Vaccines Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Rotavirus Vaccines Revenue Market Share, 2018-2029
Figure 20. By Region - Global Rotavirus Vaccines Sales Market Share, 2018-2029
Figure 21. By Country - North America Rotavirus Vaccines Revenue Market Share, 2018-2029
Figure 22. By Country - North America Rotavirus Vaccines Sales Market Share, 2018-2029
Figure 23. US Rotavirus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Rotavirus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Rotavirus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Rotavirus Vaccines Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Rotavirus Vaccines Sales Market Share, 2018-2029
Figure 28. Germany Rotavirus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 29. France Rotavirus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Rotavirus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Rotavirus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Rotavirus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Rotavirus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Rotavirus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Rotavirus Vaccines Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Rotavirus Vaccines Sales Market Share, 2018-2029
Figure 37. China Rotavirus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Rotavirus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Rotavirus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Rotavirus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 41. India Rotavirus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Rotavirus Vaccines Revenue Market Share, 2018-2029
Figure 43. By Country - South America Rotavirus Vaccines Sales Market Share, 2018-2029
Figure 44. Brazil Rotavirus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Rotavirus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Rotavirus Vaccines Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Rotavirus Vaccines Sales Market Share, 2018-2029
Figure 48. Turkey Rotavirus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Rotavirus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Rotavirus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Rotavirus Vaccines Revenue, (US$, Mn), 2018-2029
Figure 52. Global Rotavirus Vaccines Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Rotavirus Vaccines by Region, 2022 VS 2029
Figure 54. Rotavirus Vaccines Industry Value Chain
Figure 55. Marketing Channels
